Intel's SambaNova move could trigger a wave of strategic acquisitions as tech giants scramble to secure AI chip capabilities. Smaller players with unique technologies might become prime takeover targets.
The explosive growth in artificial intelligence is driving unprecedented demand for specialised chips. Companies across the semiconductor value chain are positioned to benefit from this multi-year trend.
From chip manufacturers to testing services, the entire semiconductor ecosystem is experiencing increased investment as AI becomes the industry's top priority.
Market capitalisation breakdown for the 'Semiconductor Power Plays: The AI Arms Race' basket.
NVDA: $4.93T
INTC: $191.40B
TSM: $1.27T
Intel's potential acquisition of AI chip startup SambaNova represents a strategic shift in the semiconductor industry. This move highlights the intense competition and consolidation happening as established players rush to compete with AI leaders like NVIDIA. We believe this trend creates opportunities across the entire semiconductor ecosystem, from chip designers to manufacturing partners.
This group spans the complete semiconductor value chain - from industry giants like Intel and NVIDIA to specialised AI hardware firms and critical manufacturing partners like TSMC and ASML. The theme captures both the consolidation trend and the underlying growth in AI hardware demand. These companies benefit from increased investment and strategic acquisitions in the sector.
Each stock was handpicked by professional analysts based on their role in the AI semiconductor ecosystem. The selection includes potential acquisition targets, dominant market leaders, essential supply chain partners, and innovative companies developing next-generation AI technologies. This diversified approach provides exposure to multiple ways the AI arms race could unfold.
Intel's reported negotiation to acquire AI chip startup SambaNova signals a major strategic push to compete in the rapidly growing AI hardware market. This move highlights a broader investment opportunity focused on the consolidation and innovation within the semiconductor industry.
Published on October 31
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full Insight
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+115.32%
On average, analysts expect assets in this group to grow 115.32% over the next year.
12 of 15 assets in this group are rated Buy by professional analysts.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
